Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mineralocorticoid receptor [729-984] (Homo sapiens (Human)) | BDBM238161 (US10017502, Example 5a | US9394291, 5a) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 16 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca AB US Patent | Assay Description Test A1 and A2: In order to identify binding to the human MR LBD a scintillation proximity assay (SPA) was adapted to the 384-well format. The MR-LBD... | US Patent US10017502 (2018) BindingDB Entry DOI: 10.7270/Q2862JSV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mineralocorticoid receptor [729-984] (Homo sapiens (Human)) | BDBM238161 (US10017502, Example 5a | US9394291, 5a) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 16 | n/a | n/a | n/a | n/a | 7.5 | n/a |
AstraZeneca AB US Patent | Assay Description Test A1: Briefly, in Test A1 the assay was run in 384 well format in 10 mM Tris-HCl, pH 7.5, 0.5 mM EDTA 20 mM NaMoO4, 0.1 mM DTT and 10% glycerol at... | US Patent US9394291 (2016) BindingDB Entry DOI: 10.7270/Q2125RJS | |||||||||||
More data for this Ligand-Target Pair |